The pharma company has confirmed reports following patient testimonials and warnings online.
Italian nonprofit Fondazione Telethon and US nonprofit Orphan Therapeutics Accelerator are collaborating to bring curative ...
Reverse mergers promise fast access to public markets – but DeeDee DeMan warns founders that leadership and governance readiness often lag behind.
The firm has closed an oversubscribed Series B, fueling two bold TCR-bispecific programs targeting cancer and autoimmune ...
Alethio Therapeutics has closed an oversubscribed $90 million Series A, providing the capital to advance to clinical stage.
AbbVie is paying up front and betting on a Japanese biotech's gut-restricted molecule to tackle inflammatory bowel disease ...
Boehringer Ingelheim and Microsoft are partnering to build AI-driven digital patient twins that simulate disease progression ...
The biotech has raised $25 million to scale its human cell models, targeting industry-standard status as drug discovery ...
Anthropic wants to use AI to address common bottlenecks in clinical trials and says collaborations with B-MS and Enveda – as ...
GSK leader shares tips on how to always keep mature brand speaker programs relevant, credible and compliant over time.
Some have called this announcement a "yellow light" or "backdoor" approval of these gray-market peptides. However, the HHS ...
Rhythm Pharmaceuticals has amended its exclusive license agreement with LG Chem for bivamelagon, an oral small-molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results